Mandate

Vinge advises J.P. Morgan, Nordea and SEB Enskilda in connection with SAS rights issue

February 09, 2010

Vinge is advising J.P Morgan, Nordea and SEB Enskilda in connection with SAS AB’s new issue of ordinary shares for approximately SEK 5 billion with pre-emption rights for the company’s existing shareholders. J.P. Morgan, Nordea and SEB Enskilda which are acting as Joint Global Co-ordinators, Joint Lead Managers and Joint Bookrunners in the rights issue have, together with DnB NOR Markets, the Royal Bank of Scotland and Danske Markets, confirmed their willingness, subject to certain conditions, to severally enter into underwriting agreements in respect of 42.4 per cent of the shares in the issue.

SAS AB is listed on NASDAQ OMX Stockholm, NASDAQ OMX Copenhagen and Oslo Børs.

Vinge’s team primarily consisted of partners Göran Nyström, Rikard Stenberg and Lennart Larsson together with associates Johan Thiman, Johan Norström and Mårten Svensson.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024